Three insights:
1. Tactoset is intended for the treatment of bone voids and other bone defects caused by trauma or age-related degeneration.
2. The therapy fuses calcium phosphate with Anika’s hyaluronic acid to enhance procedural efficiency and ease of use.
3. Tactoset is provided in a kit with an aqueous solution in a pre-loaded syringe and a dry powder that must be mixed intraoperatively to form a cohesive paste prior to administration.
More articles on devices:
6 hospitals adding robotic systems for spine, orthopedics
Royal Biologics launches allograft for spine, neurosurgery
17 patients sue Mizzou BioJoint Center over knee replacement failures
